Open AccessTenofovir in the treatment of naïve and refractory chronic Hepatitis B: A single center experience in Saudi Arabia
Author(s) -
Fahad Alsohaibani,
Noura Alturaif,
Ahmed Abdulshakour,
Saad Alghamdi,
Alfadel Alshaibani,
Hamad Al-Ashgar,
Khalid Al-Kahtani,
I Kagevi
Publication year - 2015
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/1319-3767.164189
Subject(s) - medicine , gastroenterology , hbsag , hbeag , refractory (planetary science) , seroconversion , chronic hepatitis , hepatology , viral load , retrospective cohort study , adverse effect , hepatitis b virus , immunology , virus , physics , astrobiology
Tenofovir disoproxil fumarate (TDF) is a nucleotide analog used in the treatment of chronic hepatitis B (CHB) infection. This study evaluated the efficacy of TDF in achieving undetectable HBV DNA after 48 weeks of treatment in a Saudi cohort of CHB patients.